Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

Jane Wang, PhD
VP and Head of Delivery and Process Devlopment at Tessera Therapeutics
Speaker

Profile

Jane is the Vice President and Head of Delivery Technologies and Process Development at Tessera Therapeutics where she works on technology development to enable in vivo gene editing therapies. Prior to joining Tessera, she was technical lead of the nanoparticle program at Verily Life Sciences, where she worked on a variety of delivery technologies including LNP barcoding and extrahepatic nanoparticle delivery. Her background is in drug delivery, chemistry and enzyme engineering and she holds a PhD in Chemistry from UC Berkeley and a BS from the California Institute of Technology in Chemistry.

Agenda Sessions

  • Delivery of Gene Writers to Hematopoetic Stem Cells towards an In Vivo Therapy for Sickle Cell Disease

    , 11:15am
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Jane at TIDES USA: Oligonucleotide & Peptide Therapeutics